Skip to content
Krsnaa Diagnostics logo

Krsnaa Diagnostics

KRSNAA NSE
₹483.05 −2.75 (−0.57%)
P/E
15.84
View as Markdown
MCP
Close 4 Nov 2026 ₹483.05 −270.30 −35.9% 1Y
Start ₹753.35

Key Fundamentals

MicrocapHealthcare ServicesHealthcare

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
12.70%
Debt to Equity
0.54
EPS (TTM)
₹30.49
Book Value
₹320.19
Market Cap
—
P/E (TTM)
15.84
P/B
1.51
ROE
10.90%
Dividend Yield
0.41%
EBITDA
₹255 Cr
52W High
₹838.00
52W Low
₹463.10
Day Range
₹480.75 – ₹492.45
Volume
59,618

Peer Comparison

Healthcare › Healthcare Services › Healthcare Service Provider

Krsnaa Diagnostics peer comparison
Dr Lal Pathlabs
₹2,029.4062.75₹32,036 Cr13.580.26%22.30%28.00%₹2,891 Cr₹545 Cr
Vijaya Diagnostic Centre
₹1,424.6078.15₹14,588 Cr15.330.14%18.30%20.50%₹857 Cr₹187 Cr
Metropolis Healthcare
₹581.2559.74₹11,437 Cr8.030.88%13.60%17.80%₹1,710 Cr₹203 Cr
Thyrocare Technologies
₹495.5044.72₹7,723 Cr14.252.90%28.40%35.40%₹876 Cr₹176 Cr
Nephrocare Health Services
₹622.35148.53₹5,903 Cr5.610.00%8.83%15.30%₹1,053 Cr₹85 Cr
Suraksha Diagnostic
₹333.0548.41₹1,717 Cr7.080.15%14.20%17.30%₹325 Cr₹35 Cr
Krsnaa Diagnostics (this company)
₹483.0515.84₹1,571 Cr1.510.41%10.90%12.70%₹726 Cr₹98 Cr
Median 7 companies₹581.2559.74₹7,723 Cr8.030.26%14.20%17.80%₹876 Cr₹176 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

48 Average

Data confidence 98/100

Category scores

Quality
65
Good
Returns, margins, earnings quality 22% weight
Valuation
74
Strong
Cheap vs sector & own history 24% weight
Growth
21
Poor
Sales & profit trajectory 9% weight
Financial Health
28
Poor
Solvency, leverage, coverage 9% weight
Momentum
19
Poor
Trend strength, vol-adjusted 12% weight
Ownership
33
Poor
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

No strengths listed

Weaknesses

5
  • The company has delivered a poor sales growth of 11.8% over past five years.
  • Promoter holding is low: 27.1%
  • Company has a low return on equity of 9.26% over last 3 years.
  • Company has high debtors of 163 days.
  • Working capital days have increased from 25.4 days to 65.9 days

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1243
OscillatorsBullish243
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
28.32
Bullish
MACD (12,26,9)
−14.85
Bearish
SMA (50)
538.01
Bearish
SMA (200)
579.41
Bearish

As of

Analyst Rating

Based on 2 analysts
BUY100%

2 of 2 analysts rate Buy, 0 Hold, 0 Sell.

As of

BUY
2
100%
HOLD
0
0%
SELL
0
0%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+34.37%
5Y+11.78%
3Y+14.20%
1Y+1.32%
TTM+4.46%

Net profit

Net profit growth by window
10YTurned to profit
5Y−11.05%
3Y+17.19%
1Y+24.10%
TTM+15.29%

Operating cash flow

Operating cash flow growth by window
10Y—
5Y+2.40%
3Y+21.34%
1Y+50.56%
TTM—

10Y: The statements do not go back far enough for this window.

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+30.82 pp
5Y+7.08 pp
3Y+4.10 pp
1Y+1.93 pp
TTM+1.09 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹57.00 Cr
Mar 2018₹108 Cr
Mar 2019₹147 Cr
Mar 2020₹258 Cr
Mar 2021₹396 Cr
Mar 2022₹455 Cr
Mar 2023₹464 Cr
Mar 2024₹590 Cr
Mar 2025₹682 Cr
Mar 2026₹691 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹2.00 Cr
Mar 2018−₹60.00 Cr
Mar 2019₹12.00 Cr
Mar 2020−₹112 Cr
Mar 2021₹185 Cr
Mar 2022₹71.00 Cr
Mar 2023₹64.00 Cr
Mar 2024₹59.00 Cr
Mar 2025₹83.00 Cr
Mar 2026₹103 Cr

Analyst Forecasts

Forecast For
FY27 consensus · EBITDA
₹242 Cr −5.3% vs FY26
Reported High Mean Low

Quarterly Results

₹ Cr
KRSNAA quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
132
147
152
159
163
179
165
175
176
183
159
173
211
240
Expenses
100
116
113
116
120
126
117
121
126
125
112
116
154
168
Operating Profit
32
31
38
43
43
52
48
53
50
58
48
57
57
72
OPM %
24%
21%
25%
27%
26%
29%
29%
31%
29%
32%
30%
33%
27%
30%
Other Income
4
4
4
4
7
5
9
4
4
4
4
31
7
6
Interest
2
3
4
7
5
6
6
7
6
8
8
12
15
15
Depreciation
16
19.46
21
18
21
22
23
22
22
23
23
22
28
29
PBT
19
14
17
22
24
28
28
29
26
31
21
54
22
34
Tax %
18%
20%
20%
17%
23%
23%
24%
28%
26%
24%
22%
20%
26%
25%
Net Profit
15
11
14
18
18
22
22
21
20
23
16
43
16
25
EPS (₹)
4.86
3.6
4.21
5.7
5.63
6.8
6.69
6.53
6.03
7.16
5.08
13.37
4.88
—

Sep 2026: from the results filed on 2 Nov 2026, ahead of the full statement, so some rows are blank.

Profit & Loss

₹ Cr
KRSNAA profit and loss, annual, ₹ crore
Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
36
57
108
147
258
396
455
464
590
682
691
726
Expenses
35
42
169
87
373
302
320
340
444
485
478
507
Operating Profit
0
15
−62
60
−114
94
135
124
146
197
213
219
OPM %
0.6%
26%
−57%
41%
−44%
24%
30%
27%
25%
29%
31%
30%
Other Income
3
4
3
2
13
265
15
19
17
26
43
47
Interest
6
6
8
16
25
26
18
8
16
25
34
42
Depreciation
5
10
18
26
32
37
41
54
75
88
90
96
PBT
−7
2
−84
21
−158
295
90
82
72
110
132
128
Tax %
6%
8%
−29%
40%
−29%
37%
21%
23%
19%
24%
22%
—
Net Profit
−8
2
−60
12
−112
185
71
64
59
83
103
99
EPS (₹)
−15.05
4.01
−117
24.15
−217
285
22.52
20.23
18.14
25.65
31.65
30.49
Div. Payout %
0%
0%
0%
0%
0%
0%
11%
14%
14%
11%
6%
—

Balance Sheet

₹ Cr
KRSNAA balance sheet, annual, ₹ crore
Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
5
5
—
5
5
6
16
16
16
16
16
Reserves
4
6
—
43
−217
−17
671
727
799
877
976
Borrowings
131
102
—
330
246
474
41
32
160
202
531
Other Liabilities
24
63
—
115
596
146
149
134
197
188
295
Total Liabilities
163
176
—
493
630
609
877
909
1,172
1,283
1,818
Fixed Assets
59
116
—
223
275
309
386
471
647
668
651
CWIP
20
6
—
42
9
4
28
25
10
3
208
Investments
0
0
—
0
0
0
0
0
0
32
58
Other Assets
85
53
—
228
345
297
463
413
514
581
902
Total Assets
163
176
—
493
630
609
877
909
1,172
1,283
1,818

Cash Flow

₹ Cr
KRSNAA cash flow, annual, ₹ crore
Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
59
—
61
38
119
129
75
24
89
134
Investing
—
−53
—
−201
−77
−67
−241
−109
−129
−102
−391
Financing
—
−37
—
145
6
20
176
−33
84
14
278
Net Cash Flow
—
−31
—
4
−33
71
64
−66
−20
1
22
Free Cash Flow
—
6
—
−42
−39
50
−2
−59
−169
−21
−80
CFO/OP
—
410
—
114
−42
134
100
71
30
55
75

Ratios

KRSNAA financial ratios, annual
Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
87
91
—
140
87
69
48
59
110
152
163
Inventory Days
21
24
—
89
—
—
—
—
—
—
—
Days Payable
76
99
—
878
—
—
—
—
—
—
—
Cash Conversion Cycle
32
15
—
−650
87
69
48
59
110
152
163
Working Capital Days
−428
−119
—
−234
−133
−82
−21
16
−18
28
66
ROCE %
—
7%
—
—
−65%
129%
18%
12%
10%
13%
13%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Krsnaa Diagnostics insights

60 extracted metrics across FY16–FY27.

Shareholding Pattern

As of Sep 2026

  • Public 28.57%
  • Promoters 27.11%
  • Others 25.97%
  • DIIs 14.50%
  • FIIs 3.84%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Krsnaa Diagnostics

What does Krsnaa Diagnostics Ltd do?
Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns.
Where is Krsnaa Diagnostics Ltd (KRSNAA) listed?
Krsnaa Diagnostics Ltd trades as KRSNAA on the NSE and under code 543328 on the BSE.
Which sector does Krsnaa Diagnostics Ltd belong to?
Krsnaa Diagnostics Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the PE ratio of Krsnaa Diagnostics Ltd?
Krsnaa Diagnostics Ltd trades at a PE ratio of 15.84 as of 4 Nov 2026, on earnings per share of ₹30.49, against a book value of ₹320.19 per share.
What is the 52-week high and low of Krsnaa Diagnostics Ltd?
Over the last 52 weeks Krsnaa Diagnostics Ltd has traded between ₹463.1 and ₹838 as of 4 Nov 2026.
Does Krsnaa Diagnostics Ltd pay dividends?
Krsnaa Diagnostics Ltd has a dividend yield of 0.41%.
What is the Return on Equity (ROE) of Krsnaa Diagnostics Ltd?
Krsnaa Diagnostics Ltd reported a return on equity of 10.90%. Its debt-to-equity ratio is 0.54.

Company Information

Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns.

Website krsnaadiagnostics.com
Listed 16 Aug 2021
Face Value ₹5

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/KRSNAA.md for Krsnaa Diagnostics Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month